Simvastatin Plus Rifaximin in Decompensated Cirrhosis
NCT03150459
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Cirrhoses, Liver
Interventions
DRUG:
Simvastatin 20 mg
DRUG:
Simvastatin 40mg
DRUG:
Rifaximin 400 mg
OTHER:
Placebo of Simvastatin
OTHER:
Placebo of Rifaximin
Sponsor
Judit Pich